 | • レポートコード：QY2207C3499 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界の薬物溶出性ミクロスフェアの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に薬物溶出性ミクロスフェアの世界市場のxxx％を占める「容量2ml」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「腫瘍」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の薬物溶出性ミクロスフェアの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの薬物溶出性ミクロスフェア市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの薬物溶出性ミクロスフェア市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 薬物溶出性ミクロスフェアのグローバル主要メーカーには、Terumo、Balton、Boston Scientific、Cook Medical、Merit Medical、Varian Medicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 薬物溶出性ミクロスフェア市場は、種類と用途によって区分されます。世界の薬物溶出性ミクロスフェア市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 容量2ml、容量4ml、その他 【用途別セグメント】 腫瘍、血管塞栓症、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 薬物溶出性ミクロスフェア製品概要 - 種類別市場（容量2ml、容量4ml、その他） - 用途別市場（腫瘍、血管塞栓症、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の薬物溶出性ミクロスフェア販売量予測2017-2028 - 世界の薬物溶出性ミクロスフェア売上予測2017-2028 - 薬物溶出性ミクロスフェアの地域別販売量 - 薬物溶出性ミクロスフェアの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別薬物溶出性ミクロスフェア販売量 - 主要メーカー別薬物溶出性ミクロスフェア売上 - 主要メーカー別薬物溶出性ミクロスフェア価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（容量2ml、容量4ml、その他） - 薬物溶出性ミクロスフェアの種類別販売量 - 薬物溶出性ミクロスフェアの種類別売上 - 薬物溶出性ミクロスフェアの種類別価格 ・用途別市場規模（腫瘍、血管塞栓症、その他） - 薬物溶出性ミクロスフェアの用途別販売量 - 薬物溶出性ミクロスフェアの用途別売上 - 薬物溶出性ミクロスフェアの用途別価格 ・北米市場 - 北米の薬物溶出性ミクロスフェア市場規模（種類別、用途別） - 主要国別の薬物溶出性ミクロスフェア市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの薬物溶出性ミクロスフェア市場規模（種類別、用途別） - 主要国別の薬物溶出性ミクロスフェア市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の薬物溶出性ミクロスフェア市場規模（種類別、用途別） - 主要国別の薬物溶出性ミクロスフェア市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の薬物溶出性ミクロスフェア市場規模（種類別、用途別） - 主要国別の薬物溶出性ミクロスフェア市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの薬物溶出性ミクロスフェア市場規模（種類別、用途別） - 主要国別の薬物溶出性ミクロスフェア市場規模（トルコ、サウジアラビア） ・企業情報 Terumo、Balton、Boston Scientific、Cook Medical、Merit Medical、Varian Medical ・産業チェーン及び販売チャネル分析 - 薬物溶出性ミクロスフェアの産業チェーン分析 - 薬物溶出性ミクロスフェアの原材料 - 薬物溶出性ミクロスフェアの生産プロセス - 薬物溶出性ミクロスフェアの販売及びマーケティング - 薬物溶出性ミクロスフェアの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 薬物溶出性ミクロスフェアの産業動向 - 薬物溶出性ミクロスフェアのマーケットドライバー - 薬物溶出性ミクロスフェアの課題 - 薬物溶出性ミクロスフェアの阻害要因 ・主な調査結果 |
Drug Elutable Microspheres absorb drugs into their matrix, which can be loaded with chemotherapeutic agents.
Market Analysis and Insights: Global Drug Elutable Microspheres Market
Due to the COVID-19 pandemic, the global Drug Elutable Microspheres market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Volume 2ml accounting for % of the Drug Elutable Microspheres global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oncology segment is altered to an % CAGR throughout this forecast period.
China Drug Elutable Microspheres market size is valued at US$ million in 2021, while the US and Europe Drug Elutable Microspheres are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Drug Elutable Microspheres landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Drug Elutable Microspheres include Terumo, Balton, Boston Scientific, Cook Medical, Merit Medical and Varian Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Drug Elutable Microspheres Scope and Segment
Drug Elutable Microspheres market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Drug Elutable Microspheres market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Volume 2ml
Volume 4ml
Others
Segment by Application
Oncology
Vascular Embolism
Others
By Company
Terumo
Balton
Boston Scientific
Cook Medical
Merit Medical
Varian Medical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Drug Elutable Microspheres Product Introduction
1.2 Market by Type
1.2.1 Global Drug Elutable Microspheres Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Volume 2ml
1.2.3 Volume 4ml
1.2.4 Others
1.3 Market by Application
1.3.1 Global Drug Elutable Microspheres Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Vascular Embolism
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drug Elutable Microspheres Sales Estimates and Forecasts 2017-2028
2.2 Global Drug Elutable Microspheres Revenue Estimates and Forecasts 2017-2028
2.3 Global Drug Elutable Microspheres Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drug Elutable Microspheres Sales by Region
2.4.1 Global Drug Elutable Microspheres Sales by Region (2017-2022)
2.4.2 Global Sales Drug Elutable Microspheres by Region (2023-2028)
2.5 Global Drug Elutable Microspheres Revenue by Region
2.5.1 Global Drug Elutable Microspheres Revenue by Region (2017-2022)
2.5.2 Global Drug Elutable Microspheres Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drug Elutable Microspheres Sales by Manufacturers
3.1.1 Global Top Drug Elutable Microspheres Manufacturers by Sales (2017-2022)
3.1.2 Global Drug Elutable Microspheres Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug Elutable Microspheres in 2021
3.2 Global Drug Elutable Microspheres Revenue by Manufacturers
3.2.1 Global Drug Elutable Microspheres Revenue by Manufacturers (2017-2022)
3.2.2 Global Drug Elutable Microspheres Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drug Elutable Microspheres Revenue in 2021
3.3 Global Drug Elutable Microspheres Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drug Elutable Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drug Elutable Microspheres Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drug Elutable Microspheres Sales by Type
4.1.1 Global Drug Elutable Microspheres Historical Sales by Type (2017-2022)
4.1.2 Global Drug Elutable Microspheres Forecasted Sales by Type (2023-2028)
4.1.3 Global Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
4.2 Global Drug Elutable Microspheres Revenue by Type
4.2.1 Global Drug Elutable Microspheres Historical Revenue by Type (2017-2022)
4.2.2 Global Drug Elutable Microspheres Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drug Elutable Microspheres Revenue Market Share by Type (2017-2028)
4.3 Global Drug Elutable Microspheres Price by Type
4.3.1 Global Drug Elutable Microspheres Price by Type (2017-2022)
4.3.2 Global Drug Elutable Microspheres Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drug Elutable Microspheres Sales by Application
5.1.1 Global Drug Elutable Microspheres Historical Sales by Application (2017-2022)
5.1.2 Global Drug Elutable Microspheres Forecasted Sales by Application (2023-2028)
5.1.3 Global Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
5.2 Global Drug Elutable Microspheres Revenue by Application
5.2.1 Global Drug Elutable Microspheres Historical Revenue by Application (2017-2022)
5.2.2 Global Drug Elutable Microspheres Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drug Elutable Microspheres Revenue Market Share by Application (2017-2028)
5.3 Global Drug Elutable Microspheres Price by Application
5.3.1 Global Drug Elutable Microspheres Price by Application (2017-2022)
5.3.2 Global Drug Elutable Microspheres Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drug Elutable Microspheres Market Size by Type
6.1.1 North America Drug Elutable Microspheres Sales by Type (2017-2028)
6.1.2 North America Drug Elutable Microspheres Revenue by Type (2017-2028)
6.2 North America Drug Elutable Microspheres Market Size by Application
6.2.1 North America Drug Elutable Microspheres Sales by Application (2017-2028)
6.2.2 North America Drug Elutable Microspheres Revenue by Application (2017-2028)
6.3 North America Drug Elutable Microspheres Market Size by Country
6.3.1 North America Drug Elutable Microspheres Sales by Country (2017-2028)
6.3.2 North America Drug Elutable Microspheres Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Drug Elutable Microspheres Market Size by Type
7.1.1 Europe Drug Elutable Microspheres Sales by Type (2017-2028)
7.1.2 Europe Drug Elutable Microspheres Revenue by Type (2017-2028)
7.2 Europe Drug Elutable Microspheres Market Size by Application
7.2.1 Europe Drug Elutable Microspheres Sales by Application (2017-2028)
7.2.2 Europe Drug Elutable Microspheres Revenue by Application (2017-2028)
7.3 Europe Drug Elutable Microspheres Market Size by Country
7.3.1 Europe Drug Elutable Microspheres Sales by Country (2017-2028)
7.3.2 Europe Drug Elutable Microspheres Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drug Elutable Microspheres Market Size by Type
8.1.1 Asia Pacific Drug Elutable Microspheres Sales by Type (2017-2028)
8.1.2 Asia Pacific Drug Elutable Microspheres Revenue by Type (2017-2028)
8.2 Asia Pacific Drug Elutable Microspheres Market Size by Application
8.2.1 Asia Pacific Drug Elutable Microspheres Sales by Application (2017-2028)
8.2.2 Asia Pacific Drug Elutable Microspheres Revenue by Application (2017-2028)
8.3 Asia Pacific Drug Elutable Microspheres Market Size by Region
8.3.1 Asia Pacific Drug Elutable Microspheres Sales by Region (2017-2028)
8.3.2 Asia Pacific Drug Elutable Microspheres Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Drug Elutable Microspheres Market Size by Type
9.1.1 Latin America Drug Elutable Microspheres Sales by Type (2017-2028)
9.1.2 Latin America Drug Elutable Microspheres Revenue by Type (2017-2028)
9.2 Latin America Drug Elutable Microspheres Market Size by Application
9.2.1 Latin America Drug Elutable Microspheres Sales by Application (2017-2028)
9.2.2 Latin America Drug Elutable Microspheres Revenue by Application (2017-2028)
9.3 Latin America Drug Elutable Microspheres Market Size by Country
9.3.1 Latin America Drug Elutable Microspheres Sales by Country (2017-2028)
9.3.2 Latin America Drug Elutable Microspheres Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Drug Elutable Microspheres Market Size by Type
10.1.1 Middle East and Africa Drug Elutable Microspheres Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drug Elutable Microspheres Revenue by Type (2017-2028)
10.2 Middle East and Africa Drug Elutable Microspheres Market Size by Application
10.2.1 Middle East and Africa Drug Elutable Microspheres Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drug Elutable Microspheres Revenue by Application (2017-2028)
10.3 Middle East and Africa Drug Elutable Microspheres Market Size by Country
10.3.1 Middle East and Africa Drug Elutable Microspheres Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drug Elutable Microspheres Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Terumo
11.1.1 Terumo Corporation Information
11.1.2 Terumo Overview
11.1.3 Terumo Drug Elutable Microspheres Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Terumo Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Terumo Recent Developments
11.2 Balton
11.2.1 Balton Corporation Information
11.2.2 Balton Overview
11.2.3 Balton Drug Elutable Microspheres Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Balton Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Balton Recent Developments
11.3 Boston Scientific
11.3.1 Boston Scientific Corporation Information
11.3.2 Boston Scientific Overview
11.3.3 Boston Scientific Drug Elutable Microspheres Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boston Scientific Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boston Scientific Recent Developments
11.4 Cook Medical
11.4.1 Cook Medical Corporation Information
11.4.2 Cook Medical Overview
11.4.3 Cook Medical Drug Elutable Microspheres Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Cook Medical Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cook Medical Recent Developments
11.5 Merit Medical
11.5.1 Merit Medical Corporation Information
11.5.2 Merit Medical Overview
11.5.3 Merit Medical Drug Elutable Microspheres Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merit Medical Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merit Medical Recent Developments
11.6 Varian Medical
11.6.1 Varian Medical Corporation Information
11.6.2 Varian Medical Overview
11.6.3 Varian Medical Drug Elutable Microspheres Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Varian Medical Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Varian Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drug Elutable Microspheres Industry Chain Analysis
12.2 Drug Elutable Microspheres Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug Elutable Microspheres Production Mode & Process
12.4 Drug Elutable Microspheres Sales and Marketing
12.4.1 Drug Elutable Microspheres Sales Channels
12.4.2 Drug Elutable Microspheres Distributors
12.5 Drug Elutable Microspheres Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drug Elutable Microspheres Industry Trends
13.2 Drug Elutable Microspheres Market Drivers
13.3 Drug Elutable Microspheres Market Challenges
13.4 Drug Elutable Microspheres Market Restraints
14 Key Findings in The Global Drug Elutable Microspheres Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer